Detalhe da pesquisa
1.
Updates in the care and management of children and adolescents with systemic lupus erythematosus.
Curr Opin Rheumatol
; 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38747320
2.
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
Lupus
; 33(4): 340-346, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38334100
3.
Assessment of hydroxychloroquine blood levels in Sjögren's disease patients: drug adherence and clinical associations.
Rheumatol Int
; 44(7): 1305-1315, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38294544
4.
Quality of life, fatigue, sleep quality, and mental health in systemic lupus erythematosus patients with a high cardiovascular risk profile.
Lupus
; 32(11): 1287-1295, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37698181
5.
Risk factors for mortality in 1528 Brazilian childhood-onset systemic lupus erythematosus patients.
Lupus
; 32(6): 781-790, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-37070932
6.
Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus.
Pediatr Nephrol
; 38(6): 1843-1854, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36409367
7.
Short-term Accrual 2019 European League Against Rheumatism/American College of Rheumatology Domains and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage in Lupus Patients With and Without Nephritis at Disease Onset.
J Clin Rheumatol
; 29(4): 190-195, 2023 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36683233
8.
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial.
Ann Rheum Dis
; 81(6): 889-897, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35193873
9.
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis.
Ann Rheum Dis
; 81(5): 710-719, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35135832
10.
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases.
Ann Rheum Dis
; 81(7): 1036-1043, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35277389
11.
SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy.
Rheumatology (Oxford)
; 61(SI2): SI169-SI174, 2022 06 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34894235
12.
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine.
Rheumatology (Oxford)
; 62(1): 480-485, 2022 12 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35639644
13.
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2.
Rheumatology (Oxford)
; 61(8): 3351-3361, 2022 08 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34664616
14.
Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases.
Brain Behav Immun
; 101: 49-56, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34954325
15.
Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the disease.
Lupus
; 31(6): 659-665, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35332823
16.
Ocular findings in asymptomatic patients with primary antiphospholipid syndrome.
Lupus
; 31(14): 1800-1807, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36239237
17.
Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis.
Lupus
; 31(1): 97-104, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34965782
18.
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.
Lupus
; 31(8): 974-984, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35593174
19.
Primary dental care treatment in primary Sjögren's syndrome: a possible role in improving salivary flow rate.
Clin Exp Rheumatol
; 40(12): 2258-2267, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36189908
20.
Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.
Clin Exp Rheumatol
; 40(7): 1258-1266, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34251312